Looking Beyond Bugs to Consider Drugs: Drug User Health and HIV/HCV Prevention and Treatment

Brianna Norton, DO, MPH
Clinical Professor of Medicine
Albert Einstein College of Medicine, New York, NY



CME VIDEOTop of page

How to Obtain CME Credit:Top of page

Click here to take the CME Evaluation and Post-Meeting Survey

About the Presenter:Top of page

Dr. Norton is an Infectious Diseases physician, researcher, and public health advocate. Dr. Norton spent the last decade at Albert Einstein College of Medicine in the Bronx, NY treating patients for HIV, Hepatitis C, and opioid use disorder in community settings such as primary care clinics, methadone treatment programs, and syringe exchange programs. She has been the PI and co-investigator on multiple NIH research grants that aimed at increasing access to quality care for people who use drugs, and also founded of one of the first drug user health clinics that was located onsite at a syringe exchange program. She has recently joined the NYS Department of Health as the Deputy Medical Director of the AIDS Institute.

Learning Objectives: Top of page

At the completion of this educational activity learners will:
1. Define Harm Reduction Principles
2. Be aware of recent HIV and HCV outbreaks among PWID (people who inject drugs)
3. Articulate how to reduce HIV and HCV infections for people who inject drugs
4. Understand the data for HCV treatment among PWID and HIV/HCV co-infected

CME Information:Top of page


This CME activity has approved for AMA PRA Category 1 Credit™ for February 20, 2024, as a live activity. This activity will also be available as an enduring activity from February 27, 2024, through February 19, 2027.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length.

Accreditation Statement:Top of page


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement: Top of page

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure Statement:Top of page

Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices, or services may be discussed in the content of a CME activity.
- Dr. James F. Braun (Course Director/Planner) has no relevant financial relationships to disclose.
- Dr. Keith M. Sigel (Moderator) has no relevant financial relationships to disclose.
- Dr. Brianna Norton (Presenter) has no relevant financial relationships to disclose. Dr. Norton submitted her slides in advance for adequate peer review and supported her presentation and clinical recommendations with the best available evidence from the medical literature.

Financial Support:Top of page

This PRN CME activity is funded in part by unrestricted educational grants from Gilead Sciences and ViiV Healthcare.

You must be logged in to post a comment. Login | Register